Sonim Files S-1 for $500M Equity Facility Amid Nasdaq Delisting Threat

TL;DR

**SONM is on life support, using a dilutive equity facility to stay afloat while facing imminent Nasdaq delisting; avoid until a clear path to profitability and compliance emerges.**

AI Summary

Sonim Technologies, Inc. (SONM) filed an S-1 registration statement on September 29, 2025, for the potential resale of up to 350,000,000 shares of common stock by Chardan Capital Markets LLC. These shares are part of a committed equity facility (ChEF Purchase Agreement) established on the same date, allowing Sonim to potentially receive up to $500.0 million in aggregate gross proceeds from Chardan. Sonim itself is not selling any securities under this prospectus and will not receive proceeds from Chardan's resale. The company is currently non-compliant with Nasdaq's minimum bid price requirement of $1.00 per share, with a last quoted sale price of $0.6277 on September 26, 2025, and must regain compliance by February 9, 2026. Additionally, Sonim is non-compliant with Nasdaq's minimum $2,500,000 stockholders' equity requirement, with a deadline of October 6, 2025, to submit a plan or regain compliance. The filing highlights significant risks, including the company's ability to meet strategic initiatives, complete an Asset Purchase Agreement, identify a reverse merger target, and maintain Nasdaq listing.

Why It Matters

This S-1 filing reveals Sonim's critical need for capital, evidenced by the $500 million committed equity facility with Chardan, and its precarious position on Nasdaq. For investors, the potential for significant dilution from the 350,000,000 shares being registered is a major concern, especially given the current share price of $0.6277. Employees and customers face uncertainty as the company navigates delisting risks and a search for strategic alternatives, including a potential reverse merger. Competitively, Sonim's struggles to meet listing requirements and secure financing suggest a weakened market position against more stable rivals, impacting its ability to innovate and retain market share in its specialized device segment.

Risk Assessment

Risk Level: high — The risk level is high due to explicit statements of non-compliance with Nasdaq listing rules, specifically the minimum bid price of $1.00 (current price $0.6277) and the minimum $2,500,000 stockholders' equity. Failure to regain compliance by February 9, 2026, and October 6, 2025, respectively, could lead to delisting, severely impacting liquidity and investor confidence.

Analyst Insight

Investors should exercise extreme caution and consider avoiding SONM shares given the high risk of delisting and significant potential for dilution from the 350,000,000 shares registered for resale. Monitor for concrete plans to regain Nasdaq compliance and evidence of successful strategic initiatives before considering any investment.

Key Numbers

• 350,000,000 — Shares of Common Stock (Maximum number of shares Chardan may offer and sell, indicating potential significant dilution.)
• $500.0 million — Potential Gross Proceeds (Maximum amount Sonim may receive from Chardan, crucial for liquidity but not guaranteed.)
• $0.6277 — Share Price (Last quoted price on September 26, 2025, significantly below Nasdaq's $1.00 minimum bid requirement.)
• $1.00 — Nasdaq Minimum Bid Price (Requirement Sonim is currently failing to meet, risking delisting.)
• $2,500,000 — Nasdaq Minimum Stockholders' Equity (Requirement Sonim is currently failing to meet, risking delisting.)
• February 9, 2026 — Nasdaq Bid Price Compliance Deadline (Critical date for Sonim to regain compliance with Nasdaq's minimum bid price.)
• October 6, 2025 — Nasdaq Equity Compliance Deadline (Critical date for Sonim to regain compliance or submit a plan for Nasdaq's minimum stockholders' equity.)
• 1-for-10 — Reverse Stock Split Ratio (Effected on July 17, 2024, to boost share price, yet still below Nasdaq minimum.)

Key Players & Entities

• Sonim Technologies, Inc. (company) — Registrant and issuer of common stock
• Chardan Capital Markets LLC (company) — Selling Securityholder and counterparty to the Committed Equity Facility
• Nasdaq (regulator) — Stock exchange where SONM is listed, with which the company is non-compliant
• Peter Liu (person) — Chief Executive Officer of Sonim Technologies, Inc.
• William N. Haddad, Esq. (person) — Legal counsel from Venable LLP
• Kirill Y. Nikonov, Esq. (person) — Legal counsel from Venable LLP
• Arif Soto, Esq. (person) — Legal counsel from Venable LLP
• $500.0 million (dollar_amount) — Maximum aggregate gross proceeds Sonim may receive from Chardan under the Purchase Agreement
• $1.00 (dollar_amount) — Nasdaq's minimum bid price requirement
• $0.6277 (dollar_amount) — Last quoted sale price of SONM common stock on September 26, 2025

FAQ

Risk Factors

• Nasdaq Listing Non-Compliance [high — regulatory]: Sonim is not in compliance with Nasdaq's minimum bid price requirement of $1.00 per share, with a last sale price of $0.6277 on September 26, 2025. The company must regain compliance by February 9, 2026, or risk delisting. Additionally, Sonim is non-compliant with the minimum $2,500,000 stockholders' equity requirement, with a deadline of October 6, 2025, to submit a plan or regain compliance.
• Reliance on Committed Equity Facility [high — financial]: The company is relying on a committed equity facility (ChEF) with Chardan Capital Markets LLC to potentially raise up to $500.0 million. However, Sonim is not guaranteed to sell any shares to Chardan, and the actual proceeds could be significantly less than the maximum amount, depending on market conditions and the company's decision to sell.
• Execution of Strategic Initiatives [high — operational]: The company faces significant risks in meeting its strategic initiatives, including the completion of an Asset Purchase Agreement and the identification of a reverse merger target. Failure in these areas could materially impact the company's future operations and financial stability.
• Potential for Significant Dilution [medium — financial]: The resale of up to 350,000,000 shares of common stock by Chardan Capital Markets LLC represents a substantial amount of shares. This could lead to significant dilution for existing shareholders if these shares are sold into the market.

Industry Context

Sonim Technologies operates in the rugged mobile device market, catering to enterprise and industrial sectors. This niche market requires devices built for harsh environments, often with specialized features for communication and data capture. Competition includes other specialized rugged device manufacturers and, to some extent, mainstream device manufacturers offering more durable models.

Regulatory Implications

Sonim faces significant regulatory risk due to its non-compliance with Nasdaq listing requirements, specifically the minimum bid price and stockholders' equity. Failure to regain compliance by the specified deadlines (October 6, 2025, for equity and February 9, 2026, for bid price) could lead to delisting, severely impacting liquidity and investor confidence.

What Investors Should Do

1. Assess the significant dilution risk associated with the potential resale of 350,000,000 shares by Chardan.
2. Evaluate the company's ability to regain Nasdaq compliance by the February 9, 2026, bid price deadline and the October 6, 2025, equity deadline.
3. Consider the uncertainty of proceeds from the committed equity facility, as Sonim is not obligated to sell shares and Chardan is not obligated to purchase them beyond the agreement's terms.
4. Review the 'Risk Factors' section of the S-1 filing thoroughly for a comprehensive understanding of potential downsides.
5. Monitor the progress of the Asset Purchase Agreement and the search for a reverse merger target as critical strategic initiatives.

Key Dates

• 2025-09-29: Filing of S-1 Registration Statement — Initiates the process for Chardan Capital Markets LLC to potentially resell up to 350,000,000 shares of common stock under a committed equity facility.
• 2025-10-06: Nasdaq Equity Compliance Deadline — Sonim must submit a plan to regain compliance with the minimum $2,500,000 stockholders' equity requirement or risk delisting.
• 2026-02-09: Nasdaq Bid Price Compliance Deadline — Sonim must regain compliance with the minimum $1.00 bid price requirement to avoid delisting from Nasdaq.

Glossary

Committed Equity Facility (ChEF)

An agreement where an investor commits to purchase shares of a company's stock at the company's discretion, up to a certain amount and over a period of time, often at market prices. (Sonim has entered into such an agreement with Chardan Capital Markets LLC, allowing it to potentially raise up to $500.0 million, but the actual proceeds are not guaranteed and depend on market conditions and Sonim's decisions.)

Selling Securityholder

An entity or individual that is offering to sell securities that they already own, as opposed to the company that originally issued the securities. (In this filing, Chardan Capital Markets LLC is the 'Selling Securityholder' offering up to 350,000,000 shares of Sonim's common stock.)

Reverse Stock Split

A corporate action where a company reduces the number of its outstanding shares by consolidating them, typically to increase the per-share price. (Sonim effected a 1-for-10 reverse stock split on July 17, 2024, in an attempt to boost its share price, but it remains below the Nasdaq minimum requirement.)

Prospectus

A legal document required by the SEC that provides detailed information about an investment offering to potential investors. (This S-1 filing serves as a prospectus for the potential resale of Sonim's common stock by Chardan.)

Year-Over-Year Comparison

This S-1 filing indicates a critical juncture for Sonim, primarily driven by its non-compliance with Nasdaq listing requirements. Unlike previous filings that might have focused on growth or product development, this document highlights severe financial distress and the urgent need for capital through a committed equity facility. The potential for substantial dilution from the resale of 350,000,000 shares by Chardan is a new and significant risk compared to prior periods. The company's ability to execute strategic initiatives like an asset purchase or reverse merger is also a heightened concern.

Key Financial Figures

• $0.001 — 0 shares of our common stock, par value $0.001 per share (“Common Stock”),
• $500.0 million — Stock by Chardan. We may receive up to $500.0 million in aggregate gross proceeds from Charda
• $1.00 — nimum bid price requirement of at least $1.00 per share and the requirement to mainta
• $2,500,000 — he requirement to maintain a minimum of $2,500,000 in stockholders’ equity for conti
• $0.6277 — Common Stock as reported on Nasdaq was $0.6277 per share. We are a “smaller rep

Filing Documents

• forms-1.htm (S-1) — 814KB
• ex5-1.htm (EX-5.1) — 10KB
• ex23-1.htm (EX-23.1) — 4KB
• ex107.htm (EX-FILING FEES) — 46KB
• ex5-1_001.jpg (GRAPHIC) — 12KB
• ex23-1_002.jpg (GRAPHIC) — 6KB
• ex23-1_001.jpg (GRAPHIC) — 28KB
• sonm_logo.jpg (GRAPHIC) — 20KB
• 0001493152-25-016055.txt ( ) — 1095KB
• ex107_htm.xml (XML) — 9KB

From the Filing

As filed with the Securities and Exchange Commission on September 29, 2025. Registration No. 333- UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION UNDER THE SECURITIES ACT OF 1933 Sonim Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 3661 94-3336783 (State or other jurisdiction of incorporation or organization) (Primary (I.R.S. Employer Identification Number) 4445 Eastgate Mall, Suite 200 San Diego, CA 92121 Telephone: (650) 378-8100 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Peter Liu Chief Executive Officer 4445 Eastgate Mall, Suite 200 San Diego, CA 92121 Telephone: (650) 378-8100 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: William N. Haddad, Esq. Kirill Y. Nikonov, Esq. Arif Soto, Esq. Venable LLP 151 W. 42 nd Street, 49 th Floor New York, NY 10036 Telephone: (212) 307-5500 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act: Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine. The information contained in this preliminary prospectus is not complete and may be changed. No securities may be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and it is not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. 29, 2025. Preliminary Prospectus SONIM TECHNOLOGIES, INC. Up to 350,000,000 Shares of Common Stock This prospectus relates to the potential offer and sale from time to time by Chardan Capital Markets LLC (“Chardan” or the “Selling Securityholder”) of up to 350,000,000 shares of our common stock, par value $0.001 per share (“Common Stock”), that have been or may be issued by us to Chardan pursuant to a ChEF Purchase Agreement, dated as of September 29, 2025 (the “Signing Date”), by and between us and Chardan (the “Purchase Agreement”) establishing a committed equity facility (the “Facility”). Such shares of our Common Stock consist of up to 350,000,000 shares of our Common Stock that we may elect, in our sole discretion, to issue and sell to Chardan, from time to time under the Purchase Agreement (the “Purchase Shares”). The actual number of shares of our Common Stock issuable will vary depending on the then current market price of shares of our Common Stock sold to Chardan under the Facility, but will not exceed th

View Full Filing

View this S-1 filing on SEC EDGAR